期刊文献+

改良换血疗法治疗新生儿重症高胆红素血症疗效观察 被引量:5

Observation on effect of improved exchange transfusion therapy for neonatal hyperbilirubinemia
在线阅读 下载PDF
导出
摘要 目的探讨改良换血疗法治疗新生儿重症高胆红素血症的临床疗效。方法对重症高胆红素血症患儿实行外周静动脉同步全自动换血疗法,比较换血前后患儿体内的胆红素、血常规指标以及临床检测指标的变化。结果总胆红素、直接胆红素、间接胆红素换血后较换血前均明显降低(P均<0.05)。血常规检测中,换血前后血红蛋白的变化较大(P<0.05),而K+、Ca2+、Cl-、Na+浓度及Plt、RBC变化不大(P均>0.05)。同时患儿换血前后体温、呼吸、心率和血压比较无显著性差异。结论改良换血疗法治疗新生儿重症高胆红素血症临床效果明显,易于操作,值得基层医院开展。 Objective It is to observe the clinical effect of improved exchange transfusion therapy in the treatment of neo- natal hyperbilirubinemia. Methods Neonates with hyperbilirubinemia were performed with peripheral vein-artery synchronized and automatically exchange transfusion therapy. The changes of bilirubin, blood routine indexes and clinical detection indica- tors before and after therapy were observed and compared. Results The levels of total bilirubin, direct bilirubin, indirect bili- rubin after therapy were markedly decreased ( all P 〈 0.05). There was much change of Hb before and after therapy (P 〈 0. 05). There was no significance difference in K+ , Ca2 + , Cl- , Na + concentration and Ph, RBC before and after therapy (all P 〉 0.05). There were no significant differences in body temperature, respiration, heart rate and blood pressure before and after therapy ( all P 〉 0.05). Conclusion Improved high exchange transfusion therapy has obvious clinical effect for neo- natal hyperbilirubinemia, it is easy to operate, and is worthy to evolve in grassroots hospitals.
出处 《现代中西医结合杂志》 CAS 2013年第29期3201-3203,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 改良换血疗法 新生儿 高胆红素血症 improved exchange transfusion neonatal hyperbilirubinemia
  • 相关文献

参考文献23

二级参考文献48

共引文献35

同被引文献41

  • 1李胜玲,赵文燕,鲁惠玲,安春艳,刘萍.150例新生儿高胆红素血症临床分析[J].中国妇幼保健,2007,22(17):2345-2346. 被引量:15
  • 2CULLEY CL, KIANG TK, GILCHRIST SE, et al. Effect of the UGTIAI 28 allele unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review[J]. Ann Pharmacother, 2013, 47(4): 561-572.
  • 3BHUTANI VK, STARK AR, LAZZERONI LC, et al. Predis- charge screening for severe neonatal hyperbilirubinemia indenti- ties infants who need phototherapy[J]. J Pediatr, 2013, 162(3):477-482.
  • 4MOYLE G, ELSE L, JACKSON A, et al. Co-administration of atazana-vir/ritonavir and zinc sulphate: impact on hyperbilirubinemia and pharmacokinetics [J]. Antimicrob Agents Chemother, 2013, 57(8): 3640-3644.
  • 5WIWANITKIT V. Hyperbilirubinemia and pelvicaliceal dilatation [J]. Iran J Pediatr, 2012, 22(1): 144-147.
  • 6HUANG HC, YANG HI, CHANG YI-I, et al. Model to predict hyperbilirubinemia in healthy term and near-term newborns with exclusive breast feeding[J]. Pediatr Neonatol, 2012, 53(6): 354- 358.
  • 7Mo Mincong. To explore the clinical risk factors of severe neonatalhyperbilirubinemia [J]. Journal of Chinese Pharmaceutical Sciences, 2013,11(04):1916+1918.
  • 8Lu Caifu. The factors of neonatal severe hyperbilirubinemia dangerous research progress of[J]. utility cardiovascular and pulmonary vascular disease journal, 2013,06 (15): 7-8.
  • 9Zhao Jie, Yang Yong, Mei Jiaping, et al. In 4875 cases the risk of neonatalhyperbilirubinemia and influence factors of [J]. Clinical Medical Journal of China(Electronic Edition), 2014,03 (19): 352-354.
  • 10匡海平.茵栀黄联合妈咪爱治疗早产儿高胆红素血症的效果观察.大家健康,2014,8(11):515.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部